Drugs that contain Beclomethasone Dipropionate
1. List of Qnasl drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7780038 | TEVA BRANDED PHARM | Dispensing apparatus with dosage counter |
Jan, 2027
(3 years from now) | |
| US10188811 | TEVA BRANDED PHARM | Nasal spray device |
Oct, 2031
(8 years from now) | |
Market Authorisation Date: 23 March, 2012
Treatment: NA
Dosage: AEROSOL, METERED;NASAL
QNASL family patents
5
United States
4
European Union
3
China
3
Spain
2
Poland
2
Slovenia
2
United Kingdom
2
RS
2
Japan
2
Denmark
2
Croatia
2
Portugal
1
Chile
1
Peru
1
Canada
1
Korea, Republic of
1
Brazil
1
Hong Kong
1
Lithuania
1
Turkey
1
Germany
1
Hungary
1
Mexico
1
New Zealand
1
EA
1
Australia
1
San Marino
1
South Africa
1
Austria
1
Singapore
1
Israel
1
Cyprus
2. List of Qvar 40 drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10086156 | TEVA BRANDED PHARM | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
| US9808587 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US11395889 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10695512 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10022509 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US9463289 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
Market Authorisation Date: 15 September, 2000
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
3. List of Qvar Redihaler drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8132712 | NORTON WATERFORD | Metered-dose inhaler |
Sep, 2028
(5 years from now) | |
| US10695512 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10022510 | NORTON WATERFORD | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10086156 | NORTON WATERFORD | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
| US10022509 | NORTON WATERFORD | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US11395889 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US8931476 | NORTON WATERFORD | Inhaler |
Jul, 2031
(8 years from now) | |
| US10561808 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
| US11395888 | NORTON WATERFORD | Inhalers and related methods |
Jan, 2038
(14 years from now) | |
| US10792447 | NORTON WATERFORD | Breath actuated inhaler |
Jan, 2039
(15 years from now) | |
| US11559637 | NORTON WATERFORD | Inhalers and related methods |
Jul, 2039
(16 years from now) | |
| US11583643 | NORTON WATERFORD | Inhalers and related methods |
Aug, 2041
(18 years from now) | |
Market Authorisation Date: 03 August, 2017
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
QVAR REDIHALER family patents
36
United States
25
European Union
17
Hong Kong
17
Japan
16
China
15
Israel
14
Korea, Republic of
14
EA
13
Spain
11
Denmark
10
Poland
9
Canada
9
South Africa
6
Hungary
6
Portugal
4
Slovenia
4
United Kingdom
4
Cyprus
3
Brazil
3
Croatia
3
Mexico
3
San Marino
2
RS
2
Australia
1
India
1
New Zealand
1
Austria
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic